Canada warns U.S. against drug import plans, citing shortage concerns

18 July 2019 - Canada opposes any U.S. plans to buy Canadian prescription drugs that might threaten the country’s drug supply ...

Read more →

Majority of patients not asked for consent before being switched to a biosimilar, survey finds

17 July 2019 - The preliminary survey results showed that 52% of patients received a letter from hospital about switching to ...

Read more →

On drug prices, Trump must resist left-wing approaches that would lead to disaster

17 July 2019 - In Friday's column, I explained why President Donald Trump and the Republicans are on their way ...

Read more →

Car shopping, handbags and wealthy uncles: the quest to explain high drug prices

17 July 2019 - High drug prices are a hot topic in politics right now. President Trump has made lowering ...

Read more →

Durect announces that the FDA agreed to file the full response to the Posimir complete response letter as a complete Class 2 resubmission

17 July 2019 - User fee goal date is 27 December 2019. ...

Read more →

Perth boy battles cystic fibrosis, with a life extending drug frustratingly out of reach

15 July 2019 - In many ways Connor Barrett is just like any other kid - he loves Peppa Pig ...

Read more →

Early payouts for health care super silly, Treasury told

18 July 2019 - The superannuation sector has warned Treasury that letting people use retirement savings to pay for private ...

Read more →

Trump to order drive for improved flu vaccine

16 July 2019 - President Donald Trump is readying an executive order that would direct HHS to overhaul the development ...

Read more →

U.S. FDA accepts Allergan's new drug application for bimatoprost sustained release in patients with open-angle glaucoma or ocular hypertension

17 July 2019 - Filing included data from the Phase 3 ARTEMIS studies, which demonstrated that the majority of patients remained ...

Read more →

FDA approves Merck’s Recarbrio (imipenem, cilastatin, and relebactam) for the treatment of adults with complicated urinary tract and complicated intra-abdominal bacterial infections where limited or no alternative treatment options are available

17 July 2019 - Merck  today announced that the U.S. FDA has approved Recarbrio (imipenem, cilastatin, and relebactam) for injection, 1.25 ...

Read more →

Kamala Harris introduces plan to lower prescription drug prices

16 July 2019 - Senator Kamala Harris unveiled a plan Tuesday to lower prescription drug prices if she's elected president. ...

Read more →

Breast cancer patients to have further NICE approved drug combination option on Cancer Drugs Fund

17 July 2019 - Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on ...

Read more →

Drug Utilisation Sub-Committee outcome statement

17 July 2019 - The outcome statement from the June 2019 Drug Utilisation Sub-Committee meeting is now available. ...

Read more →

LogicBio Therapeutics receives rare paediatric disease designation for LB-001 for the treatment of methylmalonic acidaemia

16 July 2019 -  LogicBio Therapeutics today announced the U.S. FDA has granted rare paediatric disease designation to LB-001, a ...

Read more →

Knight Therapeutics announces Health Canada has approved Nerlynx for early-stage breast cancer

16 July 2019 - Knight Therapeutics announced today that Health Canada has approved Nerlynx (neratinib) for the extended adjuvant treatment of ...

Read more →

How pharma, under attack from all sides, keeps winning in Washington

16 July 2019 - It does not seem to matter how angrily President Trump tweets, how pointedly House Speaker Nancy ...

Read more →